Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

EHC vs CON: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EHC Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

EHC Overall Winner 6-Pillar Tally: EHC 5 – 1 CON Matrix Metrics: EHC 7 – 3 CON

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Concentra Group Holdings Parent, Inc. (CON) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EHC vs CON
EHC NYSE Head-to-Head Winner
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15
CON NYSE
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
TTM Revenue $2.34B
Forward P/E 22.0x
Beta / 30D Vol 0.52β · 38% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 56
RSI-14: 55.6 · SMA20: $41.80 · SMA50: $38.66

6-Pillar Scorecard Institutional Category Breakdown (EHC 5 – 1 CON)

Columns: Metric · EHC · CON
1. Valuation Multiples EHC
Forward P/E 19.4x 22.0x
Trailing P/E 21.2x 24.5x
PEG Ratio 0.41x N/M
EV / Revenue 2.5x 3.1x
2. Growth & Scale EHC
Revenue Growth (YoY) +8.9% +8.6%
Earnings Growth (YoY) +21.6% +36.4%
TTM Revenue (USD) $6.34B $2.34B
Market Cap $13.0B $5.2B
3. Profitability & Quality EHC
Gross Margin 44.1% 29.9%
Operating Margin 18.4% 17.2%
Net Profit Margin 10.2% 9.3%
Return on Equity (ROE) 25.1% 47.2%
4. Balance Sheet & Cash Flow EHC
Cash Generation (TTM) $457M $257M
Cash Flow Margin 7.2% 11.0%
Net Cash / Leverage $2.73B Net Debt (1.05x D/E) $2.04B Net Debt (4.20x D/E)
Dividend Yield 0.58% 0.60%
5. Options & Positioning CON
Options Structure Phase CONSOLIDATION BREAKOUT
Current IV / %ile 27.0% (8th %ile) 269.9% (95th %ile)
Put/Call OI Skew 0.25x (Call-Skewed) 0.79x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat EHC
OpEx & R&D Intensity 25.7% of Rev ($1.63B) 12.7% of Rev ($297M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EHC (7) vs CON (3)
Institutional Metric EHC CON Criterion Row Edge
Market Capitalization
Scale
$13.0B $5.2B Larger Scale EHC
Trailing P/E Ratio
Valuation
21.2x 24.5x Lower Multiple EHC
Forward P/E Ratio
Valuation
19.4x 22.0x Lower Multiple EHC
Revenue Growth (YoY)
Growth
+8.9% +8.6% Higher Growth EHC
Operating Margin (TTM)
Profitability
18.4% 17.2% Higher Margin EHC
Net Profit Margin
Profitability
10.2% 9.3% Higher Margin EHC
Return on Equity (ROE)
Capital Efficiency
25.1% 47.2% Higher ROE CON
52-Week Range Position
Momentum
80% ($93–$144) 91% ($19–$44) Stronger Trend CON
Beta / 30D Volatility
Risk Regime
-0.10β · 40% Vol 0.52β · 38% Vol Lower Realized Risk CON
Unified Institutional Score
Composite Signal
52.0 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite EHC
Trailing 12M Revenue (USD)
Operating Scale
$6.34B $2.34B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
44.1% 29.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 2.5x EV/Rev N/M PEG · 3.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$457M ($2.73B Net Debt (1.05x D/E)) $257M ($2.04B Net Debt (4.20x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +1.38 pp
EHC: +6.06% · CON: +4.68%
3M Horizon CON +9.05 pp
EHC: +10.53% · CON: +19.58%
6M Horizon CON +37.91 pp
EHC: +27.33% · CON: +65.24%
1Y Horizon CON +98.16 pp
EHC: +19.42% · CON: +117.58%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period EHC Revenue CON Revenue EHC Op. Margin CON Op. Margin Margin Leader
FY2018 $4.28B N/A 13.0% N/A EHC
FY2019 $4.61B N/A 13.3% N/A EHC
FY2020 $3.57B N/A 15.8% N/A EHC
FY2021 $4.01B N/A 13.9% N/A EHC
FY2022 $4.35B $1.72B 12.4% 15.0% CON
FY2023 $4.80B $1.84B 7.3% 15.6% CON
FY2024 $5.37B $1.90B 8.5% 16.0% CON
FY2025 $5.94B $2.16B 9.5% 15.4% CON

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CON BREAKOUT
99d in phase · OBV NEUTRAL
Current IV 269.9%
IV Percentile 95th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published
CON Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.2B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 12.7% of Rev ($297M)
90D Engineering Disclosures 0 Published

Investor FAQ EHC vs CON Key Questions & Quantitative Answers

As of Nov 20, 2026, Encompass Health Corporation (EHC) is the stronger overall head-to-head candidate over Concentra Group Holdings Parent, Inc. (CON) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EHC carries a Unified Composite Score of 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin). Technically, EHC sits in a Neutral phase (RSI 49.8, CONSOLIDATION options structure) and CON sits in a Markup phase (RSI 55.6, BREAKOUT options structure).

EHC leads the Growth & Scale pillar: EHC posts +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin), compared with CON at +8.6% YoY revenue growth and +36.4% YoY earnings growth on $2.34B TTM revenue (29.9% gross margin, 17.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), EHC cumulative revenue shifted +38.8% while CON shifted +25.6%. In operating R&D and SG&A reinvestment, EHC deploys 25.7% of Rev ($1.63B) (0 90-day corporate R&D disclosures) versus 12.7% of Rev ($297M) (0 disclosures) for CON.

EHC screens cheaper on headline valuation multiples. EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin), whereas CON trades at 22.0x Forward P/E, 24.5x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (11.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EHC (25.1% ROE) versus CON (47.2% ROE) capital efficiency.

In options market volatility and institutional positioning, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk). By comparison, CON carries 269.9% implied volatility (95th %ile, Extreme (>80th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (0.52β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.